RadNet IncRadNet will deploy the newly FDA-cleared AI tools across its imaging centers, enhancing its service offering.

DeepHealth has received FDA 510(k) clearances for two new functionalities in its AI-powered Breast Suite. The first is a Breast Arterial Calcification Assessment tool that automatically identifies breast arterial calcifications on standard screening mammograms, a potential early indicator of cardiovascular disease, with over 90% sensitivity and over 88% specificity in clinical testing. The second is prior exam integration into ProFound Pro, now marketed as Mammo Dx, which automatically processes prior and current studies to track lesions and distinguish new ones, aiming to improve cancer detection rates and reduce recalls. Both additions are now commercially available in the United States and will be deployed across RadNet imaging centers.
RadNet IncRadNet will deploy the newly FDA-cleared AI tools across its imaging centers, enhancing its service offering.
Bank of America CorpDeepHealth received two FDA 510(k) clearances for its AI-powered Breast Suite, enabling commercial availability.